home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

887 rows where filing_year = 2015 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • first_quarter 225
  • third_quarter 223
  • fourth_quarter 222
  • second_quarter 217

issue_code 1

  • PHA · 887 ✖

filing_year 1

  • 2015 · 887 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1655795 AMERICAN COLLEGE OF CLINICAL PHARMACY dc2e1c42-7138-4760-9870-6ed2ed91fe95 Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2015 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   127250 0 0 2015-04-01T15:37:41.410000-04:00
1656211 ACADEMY OF MANAGED CARE PHARMACY 79a8cd80-ef0b-413d-8634-03106883b197 Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2015 first_quarter PHA Biosimilar naming - supporting Congressional action to seek FDA decision on naming and supporting FTC study of effect of naming on competition, Medicare Part D lock in and Medicare Part D issues concerning managed care pharmacy Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   219000 0 0 2015-04-04T17:21:53.030000-04:00
1656266 ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP) ab065e6a-f821-4d37-9532-db8d8c0531f4 Q1 ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP) 400637926 ANAZAOHEALTH CORPORATION 2015 first_quarter PHA Issues related to the practice of Compounding Pharmacy, DQSA Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2015-04-06T09:37:40.480000-04:00
1656268 ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP) 6d82d5d9-34ed-4996-9fb3-2e7245d8bd2c Q1 ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP) 400637926 PHYSICIAN SPECIALTY COMPOUNDING 2015 first_quarter PHA Issues related to the practice of Compounding Pharmacy, the DQSA Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2015-04-06T09:40:42.713000-04:00
1656270 ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP) 828d5e6c-ceaa-4078-9db4-dd59e17027b1 Q1 ARMORY HILL ADVOCATES (FORMERLY KNOWN AS RAWLSON POLICY GROUP) 400637926 ROCK & ASSOCIATES 2015 first_quarter PHA Issues related to Compounding Pharmacy, the DQSA Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2015-04-06T09:42:45.263000-04:00
1656713 MR. THEODORE (TED) JONES cee09d17-f986-40af-8149-76f5c13e0bc9 Q1 MR. THEODORE (TED) JONES 20926 COQUI RADIOPHARMACEUTICALS, CORP. 2015 first_quarter PHA American Medical Isotopes Production Act of 2012 that was contained in the National Defense Authorization Act for Fiscal Year 2013. Acceleration of production of 99 MO using LEU (Low Enriched Uranium). HOUSE OF REPRESENTATIVES,SENATE 39193   0 0 2015-04-07T12:01:59.220000-04:00
1656779 ROCK & ASSOCIATES 458e11f9-d2dc-4fb8-b55c-a75ce6e884c7 Q1 ROCK & ASSOCIATES 33545 BRAIDWOOD MANAGEMENT, INC. 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T14:22:22.113000-04:00
1656785 ROCK & ASSOCIATES 3b6b8351-760d-430e-b376-4693237652bf Q1 ROCK & ASSOCIATES 33545 CAPITOL HILL CONSULTING GROUP (ON BEHALF OF WELLNESS PHARMACY) 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE     0 0 2015-04-07T14:31:25.677000-04:00
1656794 ROCK & ASSOCIATES 7a4f5ade-f773-4190-9d59-16cc094b8d40 Q1 ROCK & ASSOCIATES 33545 DIAMONDBACK DRUGS 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T14:37:29.897000-04:00
1656863 NELSON MULLINS RILEY & SCARBOROUGH 989ed5d8-7eeb-4344-89d0-a8e7f0b06d24 Q1 NELSON MULLINS RILEY & SCARBOROUGH 285871 INDIVIOR (FORMERLY, RECKITT BENCKISER PHARMACEUTICALS, INC.) 2015 first_quarter PHA Any legislation and regulation to the treatment of opioid abuse. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2015-04-07T15:35:23.730000-04:00
1656901 ROCK & ASSOCIATES 3fbbe57e-90b0-4aef-9c76-aa610c02d3c9 Q1 ROCK & ASSOCIATES 33545 TOWN & COUNTRY COMPOUNDING AND CONSULTING 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T15:58:48.740000-04:00
1656916 ROCK & ASSOCIATES 0361022b-c989-4e7a-ada4-281090cf65dc Q1 ROCK & ASSOCIATES 33545 US COMPOUNDING 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T16:07:57.850000-04:00
1656928 ROCK & ASSOCIATES 03739736-356e-4621-815a-c22d81c098ba Q1 ROCK & ASSOCIATES 33545 VETERINARY PHARMACIES OF AMERICA, INC. 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T16:14:05.290000-04:00
1656938 ROCK & ASSOCIATES 4bd2cd74-49b9-40aa-893a-620bbeb716df Q1 ROCK & ASSOCIATES 33545 WEDGEWOOD VILLAGE PHARMACY, INC. 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T16:20:10.417000-04:00
1656953 ROCK & ASSOCIATES dad2fcb5-ade2-44cc-af00-3851754e8a0c Q1 ROCK & ASSOCIATES 33545 WOMEN'S INTERNATIONAL PHARMACY 2015 first_quarter PHA Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2015-04-07T16:27:20.297000-04:00
1657444 THE MATHIS HARPLE GROUP fb742eed-fbb5-416a-a27b-f6fdf6ea0b3f Q1 THE MATHIS HARPLE GROUP 322911 PILMA 2015 first_quarter PHA Patent Protection; Medicare Part D; Trans-Pacific Partnership; 12 Year Data Exclusivity HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2015-04-08T16:44:58.997000-04:00
1657545 CAPITALHILL ADVISORY e7ca1bcd-193e-419f-9867-6d2e353d9df0 Q1 CAPITALHILL ADVISORY 401103351 ASTRAZENECA PTY LIMITED 2015 first_quarter PHA Australian government policy on intellectual property and its impact on the Australian healthcare system State, Dept of (DOS)     0 0 2015-04-08T23:21:12.580000-04:00
1657547 CAPITALHILL ADVISORY 630dd0dc-ef9b-4272-8563-21312b5416f4 Q1 CAPITALHILL ADVISORY 401103351 NOVARTIS PHARMACEUTICALS PTY LTD ( AUSTRALIA) 2015 first_quarter PHA Australian government policy on intellectual property and its impact on the Australian healthcare system State, Dept of (DOS)     0 0 2015-04-08T23:23:14.047000-04:00
1657554 CAPITALHILL ADVISORY a3f46420-bfe2-4735-afeb-23effd131ba1 Q1 CAPITALHILL ADVISORY 401103351 PFIZER AUSTRALIA PTY LTD 2015 first_quarter PHA Australian government policy on intellectual property and its impact on the Australian healthcare system State, Dept of (DOS) 17650   0 0 2015-04-08T23:24:15.373000-04:00
1657558 CAPITALHILL ADVISORY 18fb3b53-b7e3-454e-a127-07e20730927c Q1 CAPITALHILL ADVISORY 401103351 SANOFI-AVENTIS AUSTRALIA PTY LTD 2015 first_quarter PHA Australian government policy on intellectual property and its impact on the Australian healthcare system State, Dept of (DOS)     0 0 2015-04-08T23:25:16.497000-04:00
1657562 CAPITALHILL ADVISORY e12fa3e4-7a12-4482-89ae-24a1e1b43114 Q1 CAPITALHILL ADVISORY 401103351 BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD 2015 first_quarter PHA Australian government policy on intellectual property and its impact on the Australian healthcare system State, Dept of (DOS)     0 0 2015-04-08T23:27:17.773000-04:00
1657564 CAPITALHILL ADVISORY 45957393-5d19-4166-8fb0-dfde7a5432bf Q1 CAPITALHILL ADVISORY 401103351 MERCK SHARP & DOHME 2015 first_quarter PHA Australian government policy on intellectual property and its impact on the Australian healthcare system State, Dept of (DOS) 5000   0 0 2015-04-08T23:28:19.147000-04:00
1657725 RED+BLUE STRATEGIES 241ff137-0be4-4dd6-bf3b-0f6c408dd87a Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2015 first_quarter PHA Rules, regulations, guidance and potential legislation specific to prescription drug pricing, generic utilization, biosimilars medications and specialty pharmacy. Issues related to the treatment of pharmacy benefit managers in federal programs. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Issues related to access and affordability for prescription medications for both government and private sector benefit programs. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-09T12:05:04.293000-04:00
1657726 MR. VINCENT A. PANVINI 98c1a67a-bac4-47e5-abfa-7c4a4d3aabf5 Q1 MR. VINCENT A. PANVINI 401008845 PHRMA 2015 first_quarter PHA Medicare Part D Rebates Importation and Medical Innovation Act Trans-Pacific Partnership Patent Protections HOUSE OF REPRESENTATIVES,SENATE 5000   0 0 2015-04-09T12:06:05.510000-04:00
1657858 RED+BLUE STRATEGIES 994d2c5d-cdb8-4733-89a8-2038401500d4 Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2015 first_quarter PHA S. 633 - The Promise for antibiotics and Therapeutics for Health (PATH) Act - Focused on ensuring that the Food and Drug Administration has the necessary to tools to ensure that medically needed antibiotics are made available to the public. Issues related to ending prescription drug abuse and diversion in Medicare and Medicaid. Advancing provisions to highlight Antibiotic Innovation in the President's FY 2016 budget. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-09T14:09:47.493000-04:00
1657870 RED+BLUE STRATEGIES 0fd5ee68-bec3-4a08-aef2-43cd90461108 Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2015 first_quarter PHA CCIIO issuer letter and regulations focused on bids for 2015 and impacts on access to prescription medications and pharmacy networks. Work focused on Medicare Part D and related regulations and reports specific to pharmacy networks. Issues related to the implementation of the health care law that impact public and private sector pharmacy benefits. CMS call letter focused on changes in policies regarding mail order and pharmacy networks. Issues related to pricing and access to prescription drugs including specialty drugs and biosimilars. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-09T14:19:58.667000-04:00
1658576 PARRY, ROMANI, DECONCINI & SYMMS b8c910b2-0d8e-4bd8-a8df-9dd97bac832a 1T PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2015 first_quarter PHA Support H.R. 2985, The Combination Drug Development Incentive Act of 2013, to provide incentives for new drug development. HOUSE OF REPRESENTATIVES,SENATE 24000   0 1 2015-04-10T15:01:49.377000-04:00
1659062 AARP ec5d127b-bed3-4e41-a65d-8ee0300947ad 1A AARP 1694 AARP 2015 first_quarter PHA Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed legislation to address Pay-for-Delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B drugs. (no bill) Discussed the need for data transparency on prescription drug research and development costs and drug prices, and enhanced data reporting on coverage determinations, exception, and redeterminations under the Part D appeals process. (no bill) Centers For Medicare and Medicaid Services (CMS),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Transit Administration (FTA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA),White House Office   1860000 0 0 2015-04-13T10:45:53.880000-04:00
1659400 WILLIAMS AND JENSEN, PLLC ff485bd8-8a20-4f36-b97b-c1b9712f53e9 Q1 WILLIAMS AND JENSEN, PLLC 41454 FAGRON NORTH AMERICA 2015 first_quarter PHA Issues related to Drug Quality and Security Act (DQSA) and Pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2015-04-13T14:39:40.877000-04:00
1659594 NATIONAL RURAL HEALTH ASSOCATION 6af19dff-f455-4931-b12c-36f7d14148ec Q1 NATIONAL RURAL HEALTH ASSOCATION 53048 NATIONAL RURAL HEALTH ASSOCATION 2015 first_quarter PHA Support for 340B program HOUSE OF REPRESENTATIVES,SENATE   175000 0 0 2015-04-13T16:06:43.923000-04:00
1659645 AARP 5cfe5fae-7aaf-4ebf-a4dc-6ed32e448952 Q1 AARP 1694 AARP 2015 first_quarter PHA Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed legislation to address Pay-for-Delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B drugs. (no bill) Discussed the need for data transparency on prescription drug research and development costs and drug prices, and enhanced data reporting on coverage determinations, exception, and redeterminations under the Part D appeals process. (no bill) Centers For Medicare and Medicaid Services (CMS),Equal Employment Opportunity Commission (EEOC),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Transit Administration (FTA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Office of Management & Budget (OMB),Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,U.S. Trade Representative (USTR),Veterans Affairs, Dept of (VA),White House Office   1860000 0 0 2015-04-13T16:21:22.383000-04:00
1659718 PRINTING INDUSTRIES OF AMERICA, INC. afe08055-af87-4842-9fd3-2ea1471de9ca Q1 PRINTING INDUSTRIES OF AMERICA, INC. 32203 PRINTING INDUSTRIES OF AMERICA INC 2015 first_quarter PHA Pharmaceutical Printed Literature Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Labor Relations Board (NLRB),Occupational Safety & Health Administration (OSHA),SENATE,U.S. Postal Service (USPS)   90000 0 0 2015-04-13T16:46:42.477000-04:00
1659949 ANIMAL HEALTH INSTITUTE 47ca5493-e1bc-4c3f-ab03-8dbec7c64b92 Q1 ANIMAL HEALTH INSTITUTE 4037 ANIMAL HEALTH INSTITUTE 2015 first_quarter PHA HR 639 and S 481 - Improving Regulatory Transparency for New Medical Therapies Act;Issues related to antibiotic research and data collection; HOUSE OF REPRESENTATIVES,SENATE   30000 0 0 2015-04-14T09:11:14.937000-04:00
1660084 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS e1fe1f45-a644-4854-a593-efb950c3ba92 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2015 first_quarter PHA Contact concerning FDA authority to manage drug shortages, regulation of pharmacy compounding, and implementation of the Drug Quality and Security Act. Contact concerning the Drug Quality and Security Act, all titles. Communication with the FDA on labeling of genric medications and biosimilars. Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2015-04-14T10:34:44.793000-04:00
1660812 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION ad3e50e4-0d2d-4ac8-a00e-ad194a5d03ee Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2015 first_quarter PHA Pseudoephedrine Potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) and oppose prescription requirement (no bill number). Over-the-counter (OTC) medicines; Manufacturing and importation of OTC drugs; Mandatory recall authority of the FDA; Rx-to-OTC Switch Supporting a process within FDA that ensures clarity and timely outcomes for the FDA, applicants and stakeholders, as well as utilizing existing technologies to further streamline the prescription-to-nonprescription switch application process without changing the existing clear distinction between prescription and nonprescription medicines. Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   140000 0 0 2015-04-14T15:26:40.120000-04:00
1660864 CAPTURERX 37387a39-3fea-4305-b2f0-9e05c3514f64 Q1 CAPTURERX 401103607 CAPTURERX 2015 first_quarter PHA Advocating on behalf of the 340B prescription drug program. Promoting transparency and compliance within the 340B program. Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   50000 0 0 2015-04-14T15:44:12.210000-04:00
1661096 UNIVERSITY OF IOWA c1618be2-6c56-47bb-b2e5-0fcad8321906 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2015 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development Human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Transportation, Dept of (DOT)   86662 0 0 2015-04-14T17:12:41.713000-04:00
1661618 KATE MOSS 89156c7a-6817-4d49-8240-68f4c486d4f4 Q1 KATE MOSS 25988 CVS HEALTH 2015 first_quarter PHA Issues related to prescription drug abuse and drug supply chain safety. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2015-04-15T11:30:41.827000-04:00
1661868 ACG ADVOCACY 528d4608-b580-44aa-b671-2fde604f6ebc Q1 ACG ADVOCACY 2057 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2015 first_quarter PHA Advocacy on Medicare and Medicaid pharmacy coverage and reimbursement issues. Advocating for coverage of pharmacists services under Medicare Part B. Advocating for the passage of legislation that curbs prescription drug abuse while protecting patient access to medication. Advocating for fair and accurate Medicaid pharmacy reimbursement. Advocating for Medicare Part D changes that increase beneficiary eligibility for medication therapy management. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-15T12:45:30.787000-04:00
1662461 CHRISTY ELLERBEE CONSULTING, LLC a9b6ef56-7b55-4364-800f-f610aacb566a Q1 CHRISTY ELLERBEE CONSULTING, LLC 401103332 INDIVIOR, PLC (FKA RECKITT BENCKISER PHARMACEUTICALS, INC.) 2015 first_quarter PHA Pharmaceutical issues relevant to Indivior, PLC. HOUSE OF REPRESENTATIVES,SENATE     0 0 2015-04-15T16:01:56.997000-04:00
1662552 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 39929c99-514e-4a29-bbb7-8025c000f57e Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2015 first_quarter PHA issues related to the 340B drug discount program Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-15T16:42:03.870000-04:00
1662567 MCKENNA, LONG & ALDRIDGE b5a5e0f8-a7f5-48d5-b955-bb3a8af729b6 1A MCKENNA, LONG & ALDRIDGE 76913 PURDUE PHARMA 2015 first_quarter PHA U.S. and Canadian regulatory policies regarding prescription drug abuse HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2015-04-15T16:53:13.483000-04:00
1662653 MR. GALEN RESER c8b12f44-f633-422e-9d24-37078907168d Q1 MR. GALEN RESER 401055978 PERRIGO INC (THROUGH FTI GOVERNMENT AFFAIRS) 2015 first_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, "Restoring Access to Medication Act of 2015," H.R. 1270, S. 709. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. Monitored Fairness to Pet Owners Act. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2015-04-15T17:19:06.407000-04:00
1663081 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. e73f77db-eb90-4758-b2d2-68177edfbc10 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2015 first_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. HR 1600, Patients Access to Treatment Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE 50000   0 0 2015-04-16T08:50:53.113000-04:00
1663086 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. f45a8dcd-a6f6-4df2-8c3b-31498ee87307 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2015 first_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2015-04-16T08:53:54.377000-04:00
1663100 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. aa2fd725-fefd-4641-bd11-5c6936cd7120 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2015 first_quarter PHA HR 1600, Patient Access to Treatment Act; HR 1801 Cancer Drug Coverage Parity Act/S. 1989 Cancer Treatment Parity Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2015-04-16T08:57:58.373000-04:00
1663285 THE MADISON GROUP 1a82e482-0995-4185-9ee5-72e7236a98c9 1T THE MADISON GROUP 284050 WEST-WARD PHARMACEUTICALS 2015 first_quarter PHA Issues pertaining to generic pharmaceutical drugs. HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2015-04-16T10:06:40.193000-04:00
1663464 APOTEX CORP. 9d3d0114-ddd1-45b1-9924-468195ce941a Q1 APOTEX CORP. 310973 APOTEX CORP. 2015 first_quarter PHA FDA proposed rule, Supplemental Applications Proposing Labeling Changes For Approved Drugs And Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; House Energy & Commerce Committees 21st Century Cures discussion draft, provisions relating to federal policies regarding the discovery, approval and manufacturing of pharmaceuticals; Federal policy relating to International Nonproprietary Names for biosimilars; Federal policy relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing; Federal policy relating to the implementation of the Biologic Price Competition and Innovation Act, Title VII, Subtitle A, of Public Law 111-148, the Patient Protection and Affordable Care Act, and; Federal policy relating to the Implementation of Public Law 112-144, The Food and Drug Administration Safety and Innovation Act, Title 3, Fees Relating to Generic Drugs HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2015-04-16T10:54:22.933000-04:00
1663883 ENDO INTERNATIONAL d36f455f-1443-418b-a4b4-e28015804d7f Q1 ENDO INTERNATIONAL 40011075 ENDO INTERNATIONAL 2015 first_quarter PHA Issues related to tamper-resistant formulation of pharmaceutical drugs; Life Sciences Jobs and Investment Act. HOUSE OF REPRESENTATIVES,SENATE   500000 0 0 2015-04-16T12:08:26.770000-04:00
1663988 RED+BLUE STRATEGIES 3b88fa3a-0c19-4489-8771-d7706731f065 Q1 RED+BLUE STRATEGIES 400693064 BLUE CROSS BLUE SHIELD OF MASSACHUSETTS 2015 first_quarter PHA Issues related to opioid abuse. Issues related to state-based marketplaces. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-16T12:26:18.623000-04:00
1664021 VALENTE & ASSOCIATES 5e1c5e00-4fb4-44c7-965a-1705706a63a1 Q1 VALENTE & ASSOCIATES 45983 SAV-MOR FRANCHISING, INC. 2015 first_quarter PHA Medicare Part D HOUSE OF REPRESENTATIVES 30000   0 0 2015-04-16T12:35:34.817000-04:00
1664137 MASSACHUSETTS MEDICAL SOCIETY 00555ef8-5117-42e5-b7c9-c1a00a4cb302 Q1 MASSACHUSETTS MEDICAL SOCIETY 23975 MASSACHUSETTS MEDICAL SOCIETY 2015 first_quarter PHA S 320 - Medical Innovation Act - NIH funding Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE   90000 0 0 2015-04-16T13:03:44.847000-04:00
1664281 JOHNS HOPKINS UNIVERSITY d4163990-afa3-422d-bf3f-6cb1f0fa0629 Q1 JOHNS HOPKINS UNIVERSITY 20664 JOHNS HOPKINS UNIVERSITY 2015 first_quarter PHA Pharmaceutical drug price increases; 340B drug discount program Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2015-04-16T13:41:53.723000-04:00
1664346 AMERICAN PHARMACISTS ASSOCIATION f3ac7b00-8167-4bde-ba76-23e91fbf2309 Q1 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2015 first_quarter PHA Reimbursement of pharmacist services - HR592/S314 Transitions of care Risk evaluation and mitigation services Track and trace/supply chain Health information technology Immunizations Compounding Tele-medicine Quality rating AMP FULs Biosimiliars Drug importation Generics labeling Preferred pharmacy network - HR793 Electronic labeling Home infusion - HR605/S275 21st century cures Precision medicine/pharmacogenomics Maximum allowable cost - HR244 Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   27243 0 0 2015-04-16T13:56:32.927000-04:00
1664388 SANOFI US SERVICES INC. 477341ea-fd17-4c65-86ff-943dc55843e9 Q1 SANOFI US SERVICES INC. 56838 SANOFI US SERVICES INC 2015 first_quarter PHA General issues related to the 340B Federal Drug Pricing Program HOUSE OF REPRESENTATIVES,SENATE   1370000 0 0 2015-04-16T14:04:55.713000-04:00
1664579 KENT & O'CONNOR, INC. 52e50494-43f8-451b-baae-189d43db7fc6 Q1 KENT & O'CONNOR, INC. 21426 INTERNATIONAL WAREHOUSE LOGISTICS ASSOCIATION 2015 first_quarter PHA Legislation and regulations relating to drug and safety issues. Consumer Product Safety Commission (CPSC),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),SENATE,Surface Transportation Board (STB),Transportation, Dept of (DOT),Transportation Security Administration (TSA),U.S. Customs & Border Protection 20000   0 0 2015-04-16T14:47:33.583000-04:00
1664796 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) b67e192f-ec83-4015-b44f-d6e7cfcc66c0 Q1 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 400265214 MASS GENERAL BRIGHAM (FORMERLY KNOWN AS PARTNERS HEALTHCARE) 2015 first_quarter PHA Issues related to pharmaceutical pricing and federal oversight by the FDA Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   223020 0 0 2015-04-16T15:40:29.367000-04:00
1664805 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 03e18e76-f87e-480a-8ff1-53a6643f908d Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2015 first_quarter PHA H.R. 793 - Ensuring Seniors Access to Local Pharmacies Act of 2015; H.R. 244 - MAC Transparency Act of 2015; Congressional Oversight of 340 B Program; Fairness to Pet Act Legislation Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   450000 0 0 2015-04-16T15:41:32.723000-04:00
1665082 340B HEALTH 08309d12-981f-435f-90cc-b97287af4565 Q1 340B HEALTH 316434 340B HEALTH 2015 first_quarter PHA The 340B Drug Discount Program, HRSA's Mega-guidance and audits of covered entities, Fiscal Year 16 Labor-HHS Appropriations. Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   258101 0 0 2015-04-16T16:55:13.623000-04:00
1665101 CAPITOL HILL CONSULTING GROUP 740d752a-514a-434c-ae5e-7edd93db4796 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2015 first_quarter PHA Controlled Drug Substances Act (21 USC 13) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2015-04-16T17:01:26.943000-04:00
1665118 PD FRAZER CONSULTING, INC. 7d3c8ac6-4af9-4cd9-a149-c3752aea920f Q1 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2015 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2015-04-16T17:13:38.820000-04:00
1665213 CALIFORNIA MEDICAL ASSOCIATION INC. 30b4a161-cb0f-4fa8-ac66-4a8d29c43a85 Q1 CALIFORNIA MEDICAL ASSOCIATION INC. 40006052 CALIFORNIA MEDICAL ASSOCIATION INC 2015 first_quarter PHA Curbing Opiod Abuse: Funding for State Prescription Drug Monitoring Programs and Increased funding for treatment. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   80000 0 0 2015-04-16T17:38:39.337000-04:00
1665266 INDEPENDENT PHARMACY COOPERATIVE aeec478b-980a-4388-aa3c-7945c7215601 Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2015 first_quarter PHA H.R. 3204 Drug Quality and Security Act providing agency information on implementation and impact on the drug supply chain. H.R. 592/S. 314 Pharmacy and Medically Underserved Areas Enhancement Act. IPC is supportive of pharmacists being recognized as providers under Medicare Part B for these areas. H.R. 793 Ensuring Seniors Access to Local Pharmacies Act. IPC is support of local pharmacies being able to participate in Medicare Part D in these underserved areas. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2015-04-16T18:06:29.630000-04:00
1665467 EMPIRE CONSULTING GROUP d034ef68-4be2-4307-8263-2c839bc0c462 Q1 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2015 first_quarter PHA Issues relating to the Medicare Prescription Drug Act; 340B Drug pricing program and drug pricing generally; patent reform proposals; S.320, Medical Innovation Act; funding for the National Institutes for Health; 2015 budget and Medicare Sustainable Growth Rate ("SGR"). HOUSE OF REPRESENTATIVES 40000   0 0 2015-04-16T22:35:36.883000-04:00
1665657 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 5a5925d1-4238-4d6e-aef1-42a4455f8b65 Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2015 first_quarter PHA Rx Pedigree (Public Law 113-54);Prescription Drug Monitoring Programs (S. 480, H.R. 1725); Prescription Drug Abuse - General issues related to Rx drug abuse, (H.R. 471, S. 483, S. 524, H.R. 953); Counterfeit Drugs; Importation of Prescription Drugs (S. 122) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   324000 0 0 2015-04-17T08:58:21.093000-04:00
1665679 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) d4070e87-f909-4999-975d-cd3a8a6996b1 1A HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2015 first_quarter PHA Rx Pedigree (Public Law 113-54);Prescription Drug Monitoring Programs (S. 480, H.R. 1725); Prescription Drug Abuse - General issues related to Rx drug abuse, (H.R. 471, S. 483, S. 524, H.R. 953, H.R. 592); Counterfeit Drugs; Importation of Prescription Drugs (S. 122) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   324000 0 0 2015-04-17T09:09:35.940000-04:00
1666796 ALKERMES, INC. 90fc80f1-b0c2-42c5-8564-866238eb05f8 Q1 ALKERMES, INC. 400458235 ALKERMES, INC. 2015 first_quarter PHA DEA regulatory transparency in controlled substances scheduling person DEA regulatory transparency in issuing research licenses and quotas Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute on Alcohol Abuse & Alcoholism (NIAA),Natl Institutes of Health (NIH),Office of Natl Drug Control Policy (NDCP),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA)   863000 0 0 2015-04-17T11:48:17.533000-04:00
1666887 NOVO NORDISK INC. 6e7dffc0-60df-493f-b1bc-3b6b0abb065e Q1 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2015 first_quarter PHA P.L. 113-54 Drug Quality and Security Act (track and trace supply chain provisions); issues regarding biosimilars; issues regarding 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,U.S. Trade Representative (USTR)   920000 0 0 2015-04-17T12:03:10.047000-04:00
1667361 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 172d3c44-8664-4b8a-8823-7fa17255a750 Q1 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 35968 SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 2015 first_quarter PHA Implementation of the radiopharmaceutical provisions of The Drug Quality and Security Act as it relates to compounding. Centers For Medicare and Medicaid Services (CMS),Energy, Dept of,Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Nuclear Regulatory Commission (NRC),Office of Science & Technology Policy (OSTP),SENATE   80000 0 0 2015-04-17T13:07:30.307000-04:00
1667475 CHAMBER HILL STRATEGIES 9ab225f5-a741-42f7-a72a-d6fa08fb403e Q1 CHAMBER HILL STRATEGIES 400645947 AMAG PHARMACEUTICALS (FORMERLY KNOWN AS LUMARA PHARMACEUTICAL) 2015 first_quarter PHA Implementation issues related to P.L. 113-54, the Drug Quality and Security Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-17T13:30:37.433000-04:00
1667637 BROWN RUDNICK LLP a171e1b3-13d4-44b8-b13d-e4e1948bdffe Q1 BROWN RUDNICK LLP 287895 APOTEX CORPORATION 2015 first_quarter PHA Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94) HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2015-04-17T13:56:58.747000-04:00
1667642 KOUNTOUPES DENHAM CARR & REID, LLC 81c40ae3-98b5-4bac-9c3a-ae74747d1713 Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY - GENERIC PHARMACEUTICAL ASSN) 2015 first_quarter PHA Policy matters related to generic pharmaceuticals and biosimilars including naming, labeling, e-labeling, access and interchangeability and changes to the Risk Evaluation and Mitigation Strategies (REMS) program as well as issues related to Energy and Commerce Committee's draft on 21st Century Cures. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE 60000   0 0 2015-04-17T13:56:59.713000-04:00
1667734 FTI GOVERNMENT AFFAIRS eff71688-1622-448b-ab8a-42ac77115f2b Q1 FTI GOVERNMENT AFFAIRS 401054971 PERRIGO, INC. 2015 first_quarter PHA Repeals a requirement enacted into law as part of the PPACA of 2010 that requires consumers to obtain a prescription in order to utilize their FSA's and HSA's to purchase over-the-counter OTC medicines, "Restoring Access to Medication Act of 2015," H.R. 1270, S. 709. FDA's proposed changes to generic drug labeling. House Energy and Commerce 21st Century Cures Initiative. Senate Health, Education, Labor and Pensions 21st Century Cures Initiative. Monitored Fairness to Pet Owners Act. HOUSE OF REPRESENTATIVES,SENATE 90000   0 0 2015-04-17T14:07:43.967000-04:00
1667778 BROWN RUDNICK LLP 946ce27c-1ceb-4dd5-a4b6-83286c0937c8 Q1 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2015 first_quarter PHA Issues relating to Implementation of P.L. 113 - 54 (Drug Quality and Security Act); H.R. 471 & S. 483 -Ensuring Patient Access and Effective Drug Enforcement Act; S. 480, H.R. 1725-relating to Prescription Drug Monitoring Programs; S. 524 & H.R. 953 relating to prescription drug abuse; S. 122 relating to importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-17T14:12:05.397000-04:00
1667925 ELI LILLY AND COMPANY a68a21c9-9005-4f00-a166-6005c4f359d8 Q1 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2015 first_quarter PHA Hospital discounts Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   1830000 0 0 2015-04-17T14:23:12.370000-04:00
1667945 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 11a3f104-d376-4535-b42d-9ac608d853be Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2015 first_quarter PHA Proposals relating to the regulation of direct to consumer prescription drug advertising Federal Communications Commission (FCC),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   410000 0 0 2015-04-17T14:24:17.277000-04:00
1667948 RED+BLUE STRATEGIES 7fae212b-0142-4c66-9939-26ae491b5018 Q1 RED+BLUE STRATEGIES 400693064 HOSPIRA 2015 first_quarter PHA Issues related to the naming of biosimilars as they enter into the national prescription drug marketplace. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-17T14:24:18.213000-04:00
1667998 BROWN RUDNICK LLP 77eb905e-b162-4614-8cb6-e044a55e4c16 Q1 BROWN RUDNICK LLP 287895 HOSPIRA, INC. 2015 first_quarter PHA Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94) HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2015-04-17T14:27:44.333000-04:00
1668103 BROWN RUDNICK LLP ce5faa67-d6fd-4956-913a-02fc27490b70 Q1 BROWN RUDNICK LLP 287895 PRIME THERAPEUTICS 2015 first_quarter PHA HR 793 - Ensuring Seniors Access to Local Pharmacies Act Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-17T14:32:20.877000-04:00
1668130 FTI GOVERNMENT AFFAIRS cec673e4-8bbc-45d6-a322-3d6b9758e475 Q1 FTI GOVERNMENT AFFAIRS 401054971 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2015 first_quarter PHA Implementation of The Drug Quality and Security Act, H.R.3204 (Public Law). HOUSE OF REPRESENTATIVES,SENATE     0 0 2015-04-17T14:33:30.653000-04:00
1668224 BROWN RUDNICK LLP e66e36e6-55f8-4f80-aa77-1080097adaa5 Q1 BROWN RUDNICK LLP 287895 AMNEAL PHARMACEUTICALS 2015 first_quarter PHA Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94); Issues relating to ANDA review and approval HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2015-04-17T14:40:21.757000-04:00
1668303 ARNALL GOLDEN GREGORY, LLP 435543c9-6edf-49af-b937-49b4a8e005cc Q1 ARNALL GOLDEN GREGORY, LLP 400713137 PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION 2015 first_quarter PHA FDA issues; Generic Drug Free User Act issues; small business relief legislation HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2015-04-17T14:44:50.237000-04:00
1668326 BROWN RUDNICK LLP 87d0e26e-ada2-494d-b971-f284f8736e60 Q1 BROWN RUDNICK LLP 287895 EXELA HOLDINGS, LLC 2015 first_quarter PHA Issues relating to ANDA review and approval Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2015-04-17T14:46:01.703000-04:00
1668617 KOUNTOUPES DENHAM CARR & REID, LLC 5e5b2e9d-8259-44c3-ad5a-ab12eb79fa4c Q1 KOUNTOUPES DENHAM CARR & REID, LLC 320918 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2015 first_quarter PHA General issues related to over the counter pharmaceuticals, potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient common in popular cold and allergy medications, and opposition to prescription requirements. Issues related to "21st Century Cures" as well as FDA and NIH modernization. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of 50000   0 0 2015-04-17T15:09:26.503000-04:00
1668648 BLUECROSS BLUESHIELD OF TENNESSEE f72b3c7f-02c2-4ee8-8082-b2c9caa8cd65 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2015 first_quarter PHA General Pharmacy Issues; specialty drug pricing HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2015-04-17T15:12:40.437000-04:00
1668929 CAPITOL HILL CONSULTING GROUP a609d730-6ba3-459c-85f4-19877576f2de Q1 CAPITOL HILL CONSULTING GROUP 72053 ENDO PHARMACEUTICALS 2015 first_quarter PHA Issues related to tamper resistant formulation of pharmaceutical drugs; Ensuring Safe Access to Prescription Medication Act of 2014 S. 2825 HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2015-04-17T15:43:11.497000-04:00
1669013 CAPITOL HILL CONSULTING GROUP f6222f94-4a3d-42f2-a144-df9b11c416e1 Q1 CAPITOL HILL CONSULTING GROUP 72053 PROFESSIONAL COMPOUNDING CENTERS OF AMERICA 2015 first_quarter PHA issues related to PL 113-54, The Drug Quality and Security Act issues related to agriculture appropriations Defense, Dept of (DOD),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-17T15:56:02.370000-04:00
1669074 THORSEN FRENCH ADVOCACY LLC 07371a46-7243-47cd-bde2-ebb45b8005f1 Q1 THORSEN FRENCH ADVOCACY LLC 400599826 ASTRAZENECA PHARMACEUTICALS LP 2015 first_quarter PHA Issues related to access to pharmaceuticals. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-17T16:02:30.550000-04:00
1669081 CAPITOL HILL CONSULTING GROUP a495f724-865e-4538-8c13-c95b99a75053 1T CAPITOL HILL CONSULTING GROUP 72053 BROWN RUDNICK, LLP, ON BEHALF OF AMNEAL PHARMACEUTICALS 2015 first_quarter PHA issues related to, but not limited to, pharmacy HOUSE OF REPRESENTATIVES,SENATE 10000   0 1 2015-04-17T16:02:34.517000-04:00
1669451 SAFEWAY INC. 9f6dea50-ee81-40a6-9e9b-01e2d0ba23ef Q1 SAFEWAY INC. 300173 SAFEWAY 2015 first_quarter PHA H.R. 592/S. 314 -- Pharmacy and Underserved Areas Enhancement Act, all provisions. Preserve Access to Community Pharmacies in TRICARE (draft proposal, no bill number). HOUSE OF REPRESENTATIVES,SENATE   150000 0 0 2015-04-17T16:33:27.717000-04:00
1669778 UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY 30fa4175-4332-4e61-a963-627cc8cf42a1 Q1 UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY 401097063 UNIVERSITY HOSPITAL-NEWARK, NEW JERSEY 2015 first_quarter PHA --340B Program support to maintain current level of funding and discounts HOUSE OF REPRESENTATIVES   48642 0 0 2015-04-17T17:10:09.643000-04:00
1669868 GENENTECH, INC 8d0970bc-02ca-4fac-a783-b78a15b7d276 Q1 GENENTECH, INC 15920 GENENTECH INC 2015 first_quarter PHA Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies; 340(b) Drug Discount Program. HOUSE OF REPRESENTATIVES,SENATE   1310600 0 0 2015-04-17T17:19:49.787000-04:00
1670146 EVERGREEN ASSOCIATES, LTD. ee68b035-6a26-42c3-8b8a-0afa825f2a41 Q1 EVERGREEN ASSOCIATES, LTD. 13984 PHARMACEUTICAL PRINTED LITERATURE ASSOCIATION 2015 first_quarter PHA - Docket ID: FDA-2007-N-0363: Electronic Distribution of Content of Labeling for Human Prescription Drug and Biological Products - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2016; Title VI- Related Agencies and Food and Drug Administration; Department of Health and Human Services, Food and Drug Administration HOUSE OF REPRESENTATIVES,SENATE,Small Business Administration (SBA) 10000   0 0 2015-04-17T18:01:18.443000-04:00
1670399 THE D MAJOR GROUP 04f115f5-d672-4451-a0c3-1afac9ea4da4 Q1 THE D MAJOR GROUP 401103162 CVS CAREMARK 2015 first_quarter PHA Issues related to preventing prescription drug abuse. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-17T21:23:23.813000-04:00
1670422 THE INGRAM GROUP LLC 21980d94-52b4-413a-8ac2-8abf51ff59ae Q1 THE INGRAM GROUP LLC 400577737 ELI LILLY AND COMPANY 2015 first_quarter PHA General issues related to the biopharmaceutical and pharmaceutical industries. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-17T21:48:44.310000-04:00
1670575 BLUESTONE STRATEGIES, LLC 5f58e9e9-e6e4-4e0c-9fde-6a1d748efbcf Q1 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2015 first_quarter PHA Pharmacy Act; Generic Brand Settlement; Generic Dispensing; Generic Biologics; Specialty Drug Issues and 21st Century Cures legislation. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2015-04-18T09:59:38.850000-04:00
1671337 THE SIMMONS & RUSSELL GROUP, LLC 54c63fc3-b50f-4222-99c5-cfd50c66248d Q1 THE SIMMONS & RUSSELL GROUP, LLC 401103235 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2015 first_quarter PHA Drug importation and the FAIR Generics legislation; An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2016 and setting forth the appropriate budgetary levels for fiscal years 2017 through 2025, S.CON.RES.11. SENATE 60000   0 0 2015-04-19T10:59:20.230000-04:00
1671524 FLYNN & ASSOCIATES, INC. f56a1691-b524-4e73-8c36-ba6522f3a57e Q1 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2015 first_quarter PHA Medicare Part-D rebates Trade agreements HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2015-04-19T14:07:32.877000-04:00
1671790 TEVA PHARMACEUTICALS USA, INC. 0b57f370-56a5-4f64-a750-d955711a9421 Q1 TEVA PHARMACEUTICALS USA, INC. 76695 TEVA PHARMACEUTICALS USA INC 2015 first_quarter PHA Prescription drug abuse; drug labeling and electronic labeling proposals; counterfeit drug proposals; FY 2016 Appropriations for Agriculture, Rural Development, Food & Drug Administration and Related Agencies; HR 406, Combination Drug Development Incentive Act of 2015; "21st Century Cures" review/initiative; HR 9, Innovation Act; HR 1353 PATIENT Act; Drug pricing proposals and issues. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)   1200000 0 0 2015-04-19T17:54:50.173000-04:00
1671919 WINNING STRATEGIES WASHINGTON 5f5f950a-a89a-453f-b53a-2b1785db4da2 Q1 WINNING STRATEGIES WASHINGTON 50796 KALEO 2015 first_quarter PHA Pharmaceutical drug development, Reducing opiod overdose deaths and S. 707 HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2015-04-19T18:51:07-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1447.051ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API